
|Articles|March 1, 2004
Liquefaction device assures safe, gentle lens removal
New Orleans-The AquaLase liquefaction device (Alcon) is a new technology for lens removal that provides the advantages of excellent safety for the cornea and posterior capsule without sacrificing efficiency, said Stephen F. Brint, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%.
3
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada
4
Collarettes common but largely stable in moderate-to-severe dry eye patients
5

















































.png)


